TRNA ribosomal binding

A brief introduction to the ribosome system is necessary to acquaint the reader with some terminology. The ribosome is the site of protein biosynthesis. Its substrates otc aa-tRNAs that cycle on and off, transferring their amino acids into the nascent protein chain according to information encoded by mRNA. Transfer RNA binds to ribosomes in at least two functionally distinct sites, which are defined in terms of peptide bond formation. The peptide donor (a pep-tRNA) is bound in the P site during peptide bond formation the peptide acceptor (an aa-tRNA) is bound in the A site. There is also some functional-- evidence of a third tRNA-ribosome binding conformation. 

Kinetics of fMet-tRNA binding to 30S ribosomal subunit Inhibition of ribosomal binding of fMet-tRNA by an antibiotic may reduce the level of initiation complex formed at equilibrium. However, if the effect of the inhibitor consists mainly of slowing down the binding reaction, its effect may appear less dramatic after a relatively long incubation time. For this... 

In the following section, we describe protocols for tests aimed at screening for compounds capable of interfering with some of the main activities of this factor, such as (a) recognition and binding of initiator tRNA (b) codon-dependent ribosomal binding of fMet-tRNA leading to the formation of a 30S or 70S initiation complex (c) ribosome-dependent hydrolysis of GTP and (d) accommodation of fMet-tRNA in the ribosomal P-site and formation of the first peptide bond (initiation dipeptide formation). 

Figure 7 The direct and indirect pathways of tRNA asparaginylation. The direct pathway consists of charging by AsnRS on tRNA " of free Asn formed with asparagine synthetase A or B. The Asn-tRNA " binds the EF-Tu factor in bacteria (or EF-1A in eukaryotes and archaea) to be carried to the ribosome, in the indirect pathway, a nondiscriminating AspRS (ND-AspRS) charges Asp on tRNA " Asp-tRNA " does not bind the eiongation factor but is converted by the tRNA-dependent trimeric amidotransferase GatCAB into Asn-tRNA ", which binds the EF-Tu factor and is carried to the ribosome where it is used for polypeptide chain elongation.

The arrangement of the individual components of a ribosome has now been determined for prokaryotic ribosomes. It is known that filamentous mRNA passes through a cleft between the two subunits near the characteristic horn on the small subunit. tRNAs also bind near this site. The illustration shows the size of a tRNA molecule for comparison. 

As the mRJSlA leaves the cell nucleus in which it was created and enters the cytoplasm, it binds with specialized structures called ribosomes, as shown in Figure 13.36. Ribosomes are microscopic complexes of rRNA and proteins, and they are the site where proteins are built. As the mRNA is scrolled sequentially over the ribosome, the anticodon end of a free tRNA molecule binds to an mRNA codon. In this manner, tRNA molecules and their tag-along amino acids are placed adjacent to one another along the mRNA strand. The amino acids then chemically bond with one another, forming a long polypeptide chain that breaks away from the tRNA as it forms. This process continues until a stop mRNA codon, for which there are no tRNA anticodons, is encountered. At this point, the primary structure of a new protein has been built. 

Not all aminoacyl-tRNA synthetases have editing sites. The cysteinyl- and tyrosyl-tRNA synthetases bind the correct substrates so much more tightly than their competitors that they do not need to edit.13,14 Similarly, since the accuracy of transcription of DNA by RNA polymerase is better than the overall observed error rate in protein synthesis at about 1 part in 104, RNA polymerases do not need to edit.15 The same should be true for codon-anticodon interactions on the ribosome. However, it is possible that accuracy has been sacrificed to achieve higher rates in this case, which is analogous to a change from Michaelis-Menten to Briggs-Haldane kinetics, and so an editing step is required.16... 

Puromycin. An antibiotic that inhibits polypeptide synthesis by competing with aminoacyl-tRNA for the ribosomal binding site A. 

Rodnina, M. V., Fricke, R., and Wintermeyer, W. (1994). Transient conformational states of aminoacyl-tRNA during ribosome binding catalyzed by elongation factor Tu. Biochemistry 33, 12267-12275. 

Anti-ribosomal antibiotics are enzyme inhibitors, and the ones that are dinically useful inhibit bacterial ribosomes far more effectively than they inhibit eukaryotic ribosomes. Many enzyme inhibitors exert their effects by binding to the active site of enzymes and thereby prevent the binding of substrates. Others block enzyme function by inhibiting conformational changes essential for enzyme activity. Anti-ribosomal antibiotics are unexceptional in this regard. They bind to the sites on both subunits to which tRNA also binds. Some block the interactions of substrates with the ribosome. Others block the tunnel and thereby prevent the nascent peptide from extending. 

Formylation of methionylated tRNA " allows differentiation of the AUG start codon from internal AUG codons (14). MetRS aminoacylates tRNA" with methionine. A formyl group is linked covalently to the charged methionine via its amino moiety by the methionyl-tRNA formyltransferase enzyme, which uses N -formyl tetrahydrofolate as the formyl donor. This fMet-tRNA molecule binds directly to the P site of the ribosome to initiate protein synthesis, as compared with the A-site to which elongator tRNAs bind. 

The ribosomal binding site that accommodates a deacylated-tRNA before... 

J. Tetracyclines bind to the A-site of the prokaryotic ribosome and prevent aminoacyl-tRNAs from binding. Thus protein synthesis is halted becanse new amino acids cannot be added to the growing protein. 

---